Cancers 2013, 5(4), 1485-1503; doi:10.3390/cancers5041485
Article

Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer

1 Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Gdańsk 80-211, Poland 2 Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw 02-091, Poland 3 Bank of Frozen Tissues and Genetic Specimens, Department of Medical Laboratory Diagnostics, Medical University of Gdańsk, Gdańsk 80-211, Poland 4 Department of Surgical Oncology, Medical University of Gdańsk, Gdańsk 80-214, Poland 5 Department of Pathomorphology, Medical University of Gdańsk, Gdańsk 80-214, Poland 6 Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk 80-211, Poland
* Author to whom correspondence should be addressed.
Received: 29 August 2013; in revised form: 7 October 2013 / Accepted: 1 November 2013 / Published: 8 November 2013
(This article belongs to the Special Issue Circulating Tumor Cells in Cancers)
PDF Full-text Download PDF Full-Text [345 KB, uploaded 8 November 2013 16:20 CET]
Abstract: Breast cancers can metastasize via hematogenous and lymphatic routes, however in some patients only one type of metastases are detected, suggesting a certain proclivity in metastatic patterns. Since epithelial-mesenchymal transition (EMT) plays an important role in cancer dissemination it would be worthwhile to find if a specific profile of EMT gene expression exists that is related to either lymphatic or hematogenous dissemination. Our study aimed at evaluating gene expression profile of EMT-related markers in primary tumors (PT) and correlated them with the pattern of metastatic spread. From 99 early breast cancer patients peripheral blood samples (N = 99), matched PT (N = 47) and lymph node metastases (LNM; N = 22) were collected. Expression of TWIST1, SNAI1, SNAI2 and VIM was analyzed in those samples. Additionally expression of CK19, MGB1 and HER2 was measured in CTCs-enriched blood fractions (CTCs-EBF). Results were correlated with each other and with clinico-pathological data of the patients. Results show that the mesenchymal phenotype of CTCs-EBF correlated with poor clinico-pathological characteristics of the patients. Additionally, PT shared more similarities with LNM than with CTCs-EBF. Nevertheless, LNM showed increased expression of EMT-related markers than PT; and EMT itself in PT did not seem to be necessary for lymphatic dissemination.
Keywords: breast cancer; lymph node metastasis; circulating tumor cells; metastasis; cancer dissemination; epithelial-mesenchymal transition

Correction

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Markiewicz, A.; Książkiewicz, M.; Seroczyńska, B.; Skokowski, J.; Szade, J.; Wełnicka-Jaśkiewicz, M.; Zaczek, A.J. Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer. Cancers 2013, 5, 1485-1503.

AMA Style

Markiewicz A, Książkiewicz M, Seroczyńska B, Skokowski J, Szade J, Wełnicka-Jaśkiewicz M, Zaczek AJ. Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer. Cancers. 2013; 5(4):1485-1503.

Chicago/Turabian Style

Markiewicz, Aleksandra; Książkiewicz, Magdalena; Seroczyńska, Barbara; Skokowski, Jarosław; Szade, Jolanta; Wełnicka-Jaśkiewicz, Marzena; Zaczek, Anna J. 2013. "Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer." Cancers 5, no. 4: 1485-1503.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert